(Q36066281)

12 August 2017

1 reference

title

Antineovascular therapy, a novel antiangiogenic approach (English)

1 reference

12 August 2017

angiogenesis inhibitor

1 reference

Kosuke Shimizu

1

1 reference

12 August 2017

Tomohiro Asai

series ordinal

2

1 reference

12 August 2017

Naoto Oku

series ordinal

3

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

Expert Opinion on Therapeutic Targets

12 August 2017

14

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

12 August 2017

9

1 reference

12 August 2017

63-76

1 reference

12 August 2017

1

1 reference

Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

12 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Fundamental Concepts of the Angiogenic Process

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Angiogenesis in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Ocular angiogenesis: translating preclinical indications to successful clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

VEGF and the quest for tumour angiogenesis factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Isolation of putative progenitor endothelial cells for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Targeting HIF-1 for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Soluble Flt-1 (soluble VEGFR-1), a potent natural antiangiogenic molecule in mammals, is phylogenetically conserved in avians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Basement membranes: structure, assembly and role in tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Get a ligand, get a life: integrins, signaling and cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

A reevaluation of integrins as regulators of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

A novel synthetic Arg-Gly-Asp-containing peptide cyclo(-RGDf==V-) is the potent inhibitor of angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Cadherins as modulators of angiogenesis and the structural integrity of blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Angiostatin binds ATP synthase on the surface of human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Angiostatin binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Thrombospondin modules and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Tumorigenesis and the angiogenic switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Direct inhibition of EGF receptor activation in vascular endothelial cells by gefitinib ('Iressa', ZD1839).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Tumour biology: herceptin acts as an anti-angiogenic cocktail.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Suppression of pulmonary metastasis by angiogenesis inhibitor TNP-470 in murine osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Structure of human methionine aminopeptidase-2 complexed with fumagillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Aminopeptidase A is a functional target in angiogenic blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

The mRNA expression of cyclo-oxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

COX-2 inhibitors. A new class of antiangiogenic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Drug delivery systems: entering the mainstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Evaluation of drug targeting strategies and liposomal trafficking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Cancer chemotherapy by liposomal 6-[12-(dimethylamino)ethyl]aminol-3-hydroxy-7H-indeno[2,1-clquinolin-7-one dihydrochloride (TAS-103), a novel anti-cancer agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Potential usage of liposomal 4beta-aminoalkyl-4'-O-demethyl-4-desoxypodophyllotoxin (TOP-53) for cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Anti-neovascular therapy using novel peptides homing to angiogenic vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Suppression of tumor growth by novel peptides homing to tumor-derived new blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Mapping tumor vascular diversity by screening phage display libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

In vivo phage display and vascular heterogeneity: implications for targeted medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Anti-neovascular therapy by liposomal DPP-CNDAC targeted to angiogenic vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Anti-neovascular Therapy by Use of Liposomes Targeted to Angiogenic Vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Anti-neovascular therapy by liposomal drug targeted to membrane type-1 matrix metalloproteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Changing therapeutic paradigms for exudative age-related macular degeneration: antiangiogenic agents and photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Photodynamic therapy targeted to tumor-induced angiogenic vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Polycation liposome enhances the endocytic uptake of photosensitizer into cells in the presence of serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Intracellular target for photosensitization in cancer antiangiogenic photodynamic therapy mediated by polycation liposome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

Molecular targets in the inhibition of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.63

21 January 2018

Identifiers

DOI

10.1517/14728222.9.1.63

1 reference

12 August 2017

1 reference